StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) bonds

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.67+0.12 (+4.71%)

Close on Nov 17, 2026Market cap $92.82MP/E –Yield –

Debt

Borrowings on the balance sheet, Jul 31, 2026

Anixa Biosciences reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Anixa Biosciences's 10-K for the period ended Apr 30, 2014

IssueAmount issuedCarrying value
8 Convertible Debenture
Convertible
$3.50M$3.50M
Convertible Debenture
Convertible
–$1.15M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.

See a number that looks wrong?